Viracta Initiates Treatment of First Patient in EBV+ Lymphoma Clinical Trial with Tractinostat

NEXT STORY
Treos Bio Announces Activation of U.S. Clinical Trial Site for Phase 1 Study of PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal Cancer
PREV STORY
Summit Therapeutics Reports Financial Results for the Fiscal Year Ended 31 January 2018
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Zenith Announces Annual General Meeting of Shareholders

CALGARY, Alberta, Oct. 02, 2017 (GLOBE NEWSWIRE) -- Zenith Capital Corp. (“Zenith” or the ...

author_avatar
NASDAQ Market News

Zai Lab Announces Presentations at June Investor Conferences

SHANGHAI, China, May 29, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based ...

author_avatar
NASDAQ Market News

International Stem Cell Corporation Expands Manufacturing Capabilities for Biomedical Products

CARLSBAD, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" ...

author_avatar
NASDAQ Market News